Despite major medical advances in the fields of allergy and respiratory medicine, there is still no definitive cure for chronic conditions such as asthma, COPD, IPF, and CF. And with research in these indications being one of the most intensely competitive areas in drug development, sponsors have only increasing pressures to deliver more effective treatments through their clinical development programs.
Quintiles Allergy and Respiratory (ART) Center of Excellence can help advance your studies in these and related indications from early clinical development to post-marketing studies. With pulmonologists, respiratory medical and senior advisors, and experienced operational staff across the globe, we will help:
integrate the scientific, therapeutic, operational, and commercial components...